Roche's (ROG.S) cobas SARS-CoV-2 Test has received U.S. authorisation for testing individuals without symptoms or reasons to suspect a COVID-19 infection, the Swiss drugmaker said on Tuesday.
"The high-throughput, highly sensitive cobas SARS-CoV-2 Test under FDA Emergency Use Authorisation can now be used to test individual or pooled samples from people without symptoms or other reasons to suspect COVID-19," Roche said in a statement.
Our Standards: The Thomson Reuters Trust Principles.
https://ift.tt/3v3NWkQ
Health
Bagikan Berita Ini
0 Response to "Roche COVID test receives U.S. greenlight for asymptomatic people - Reuters"
Post a Comment